Determining the rate at which men develop genital warts after infection with alpha genus human papillomavirus (HPV) types will provide important information for the design of prevention strategies. We conducted a cohort study of 18-21-year-old men who underwent triannual genital examinations. The 24-month cumulative genital wart incidence was 57.9% (95% confidence interval [CI], 38.1%-79.1%) among 46 men with incident detection of HPV-6 or HPV-11 infection, 2.0% (95% CI, 0.5%-7.9%) among 161 men with incident detection of infection with other HPV types, and 0.7% (95% CI, 0.2%-2.8%) among 331 men who tested negative for HPV. Our results suggest that genital warts are common after HPV-6 or HPV-11 infection in young men.
awareness, it is also likely that changes in sexual behavior play a role [3] . Genital warts incur substantial health-care costs [3] , and recent studies in the United States have estimated the annual costs associated with genital warts to be $140 million-$220 million [4, 5] . A recent analysis of clinical records showed that genital warts appeared to persist longer and incur greater treatment costs in men than in women [4] .
The prophylactic HPV-6, HPV-11, HPV-16, and HPV-18 vaccine has been approved by multiple regulatory agencies for use in girls and women 9-26 years of age since 2006, and in October 2009, the US Food and Drug Administration approved it for the prevention of genital warts in boys and men 9-26 years of age. In Australia, one of the few countries with widespread HPV vaccine coverage, a statistically significant decrease in genital warts among young women attending sexually transmitted disease clinics was recently reported [6] .
A recent review noted the lack of studies examining the typespecific progression of HPV disease [7] . Such studies are important for providing information needed for more accurate mathematical modeling of natural history, defining the effect of preventative interventions, and informing policy-makers on vaccines that target specific HPV types [7] . In the present study of sexually active young men, we determined (1) the cumulative incidence of genital warts following incident detection of specific HPV types and (2) the time between the first detection of HPV infection and genital warts among those who developed warts.
Methods. From June 2003 through April 2009, we enrolled 18-21-year-old male students attending the University of Washington into a longitudinal study of genital HPV infection. Recruitment and data collection methods have been described elsewhere [8] . Men were eligible to enroll if they reported a history of sexual activity at preenrollment screening, and 473 men were enrolled. All participants provided informed consent, and the protocol was approved by the University of Washington institutional review board.
Men were followed up with triannual genital examinations, with a maximum of 10 clinical examination visits. At each visit, external genitalia were inspected by a clinician and samples of exfoliated cells were collected from the penile shaft, glans, and scrotum by gently rubbing the genital site with a sterile piece of emery paper (grit, 600A; Wetordry Tri-M-ite; 3M) followed by a saline-moistened Dacron swab (DuPont) [8] . First-void urine samples were also self-collected. Diagnoses of genital warts were made by focused unaided visual examination by the clinician, who recorded the specific site of the lesion along with , including n p 46 40 men with HPV-6 infection, 4 men with HPV-11 infection, and 2 men with HPV-6 and HPV-11 infection) (thick solid line). The thin solid line shows the cumulative incidence of warts among men with incident infection with HPV types other than 6 or 11 ( ), and the dashed n p 161 line shows that among men with no HPV infection ( ). The numbers n p 331 of men totaled from the 3 groups is greater than the total number of men in the study because the same men who had no HPV infection at enrollment could contribute to the pool of men at risk for incident infection with HPV-6, HPV-11, or another type (similarly, men who had infection with HPV types other than 6 or 11 could later contribute to the pool of men at risk for incident infection with HPV-6 or HPV-11). The x-axis shows the number of months from the time of the first incident HPV-6 or HPV-11 infection or the first infection with types other than HPV-6 or HPV-11 or the number of months from the time of enrollment for men with no HPV infection. the number of lesions at each site. Participants were asked to part their pubic hair, lift the shaft from the scrotum, or retract their foreskin, when applicable. In cases where lesions were questionable, a hand-held 5-inch magnifying glass (magnification, ϫ5) was used. Exfoliated skin cell samples included sampling of the surface of warts that were detected on the shaft, glans, or scrotum. Samples were placed in Specimen Transport medium (Qiagen) and tested for HPV DNA by methods based on polymerase chain reaction. Samples that tested positive by generic probe were genotyped for 37 alpha genus HPV types with the use of a liquid bead microarray assay, which has been shown to have good type-specific agreement with the reverse line blot assay [9] .
Analyses were restricted to 428 men who had at least 2 visits. Ten men with genital warts at enrollment were also excluded, leaving 418 men for analysis. All 418 men provided at least 1 sample for testing at enrollment. Kaplan-Meier methods were used to estimate the cumulative incidence of genital warts after incident detection of alpha genus HPV DNA in any of the genital or urine samples. Separate estimates of cumulative incidence were determined for men with (1) incident HPV-6 or HPV-11 infection, (2) incident infections other than HPV-6 or HPV-11 infection, and (3) no HPV infection. For those in the second group, men were censored at the time they developed HPV-6 or HPV-11 infection, and for those in the third group, men were censored at the time they acquired any HPV infection. If warts were detected at the same visit when incident HPV infection was detected, the infection was assumed to have occurred first. If a participant did not have a subsequent visit after an incident HPV infection was detected, the infection was considered to have occurred 1 d prior to that visit. The median time between incident detection of HPV infection and genital warts was also determined among those who developed warts.
Results. The 418 men included in this analysis completed 2786 visits. Their mean follow-up time was 24.6 months (standard deviation [SD], 12.9 months), the mean number of visits per person was 6.7 (SD, 3.0 visits), and the median time between visits was 4.1 months (range, 1.2-12.2 months). At enrollment, the mean age of these men was 18.9 years (SD, 0.7 years) and the median lifetime number of female sex partners was 2 (range, 0-30 partners).
During follow-up, incident HPV-6 infection was detected in 40 men, incident HPV-11 infection in 4 men, incident HPV-6 and HPV-11 infections in 2 men, and incident infection with at least 1 of the remaining 35 alpha genus HPV types in 161 men. Overall, 22 men developed warts; 18 with incident HPV-6 infection, 2 with infection with types other than HPV-6 or HPV-11 (1 with HPV-18, HPV-39, HPV-51, and HPV-55 infection and 1 with HPV-84 infection), and 2 who repeatedly tested negative for HPV DNA. The 24-month cumulative incidence of warts among the 418 men was 4.2% (95% confidence interval [CI], 2.4%-7.2%) and was highest among the 46 men with incident HPV-6 or HPV-11 infection (incidence, 57.9%; 95% CI, 38.1%-79.1%). Among those with incident infection with alpha genus HPV types other than HPV-6 or HPV-11 ( ), the 24-month cumulative incidence was 2.0% (95% n p 161 CI, 0.5%-7.9%), and among those who tested negative for HPV DNA ( ), the incidence was 0.7% (95% CI, 0.2%-2.8%) n p 331 (Figure 1) .
Among the 18 men with incident HPV-6 or HPV-11 infection who developed warts, the median time between incident detection of infection and genital warts was 11.0 months (interquartile range [IQR], 0-16.1 months); 5 (27.8%) of the 18 men were given diagnoses of warts at the same visit when incident HPV-6 infection was first detected. On the basis of the KaplanMeier analysis, 17 (58%) of 46 men with incident HPV-6 or HPV-11 infection developed warts by 21 months, and among this 58%, the median time to wart development was 10.6 months. Among the 4 men who developed warts without evidence of HPV-6 or HPV-11 infection, warts developed 8.9 months after incident HPV-18, HPV-39, HPV-51, and HPV-55 infection in 1 man, 4.7 months after incident HPV-84 infection in another man, and 3.7-7.3 months after enrollment in the remaining 2 men who tested negative for HPV DNA. The patterns of HPV type-specific persistence and wart detection among the 22 men who developed genital warts are shown in Figure 2 . Among these 22 men, 96 individual wart lesions were found at the time of diagnosis (median, 3 lesions; range, 1-15 lesions). Thirty-four wart lesions were found on the pubis (15 lesions in a single individual), 33 on the shaft, 22 on the base of the shaft, 4 on the meatus (all 4 lesions in a single individual), 2 on the scrotum, and 1 on the crural fold. All men with warts were treated with liquid nitrogen, but standardized information on the outcome of treatment was unavailable.
Discussion. Consistent with the literature [1] , genital wart development was associated with incident HPV-6 infection in this cohort of young men. Similar to the results of other studies and to those of our female university student cohort study [10] , HPV-6 infection was more common than HPV-11 infection. In our female cohort study, 57% of women with incident HPV-6 or HPV-11 infection developed warts within 12 months and 64% within 24 months [10] . In our male cohort study, 30% of those with incident HPV-6 or HPV-11 infection developed warts within 12 months whereas almost 60% developed warts by 24 months. The 12-month cumulative incidence of warts following incident HPV-6 or HPV-11 infection was higher than that reported recently for the placebo arm of the quadrivalent HPV vaccine trial in young men (30% vs 23%) [11] . Although this difference is not statistically significant, it is possibly due to shorter intervals between follow-up examinations (4 months vs 6 months) and to the absence of histological confirmation and genotyping of wart tissue in the present study.
Compared with that for our female cohort, the median time between incident HPV-6 or HPV-11 infection and the detection of warts among those who developed warts was ∼3-fold longer for the male cohort: the median time between incident HPV-6 or HPV-11 detection and wart development among women who developed warts was 2.9 months (IQR, 0-5.7 months) [10] , whereas among men the median time was 11 months (IQR, 0-16.1 months).
A limitation in our study is that we did not specifically test the wart tissue for HPV DNA and the presence and type of HPV in the wart tissue remain unknown. However, only 2 of 161 men with incident infections with alpha genus HPV types other than 6 or 11 developed warts, and DNA of HPV-6 or HPV-11 was detected in exfoliated superficial cell samples from 14 of the 22 men with warts at the time of diagnosis. Multiple infections were common, and we were unable to reliably evaluate the natural history of incident infection with HPV-6 or HPV-11 alone; among the 46 men with incident HPV-6 or HPV-11 infection, there were only 4 men who had no other types detected before, concomitantly, or after incident HPV-6 or HPV-11 infection. Among these 4 men, none developed warts. Additional limitations include our relatively small sample size (only 6 men acquired HPV-11 infection and none of these developed warts) and the potential for limited generalizabilty. Although male university students are likely to be different from similarly aged men who are not in college, it is important to note that, according to the National Center for Educational Statistics, ∼65% of US men aged 16-24 years who completed high school in the previous year were enrolled in college [12] .
Findings from our male and female cohorts indicate that wart development following incident HPV-6 or HPV-11 infection appears to take longer in young men than in young women. Interestingly, recent studies have found that wart incidence in men appears to peak at a later age than that in women [3] . A recent study of a large commercially insured population in the United States found that wart incidence in women peaked at 20-24 years of age, whereas in men it peaked at 25-29 years of age [5] . The 1999-2004 National Health and Nutrition Examination Survey performed among ∼8500 sexually active US men and women aged 18-59 years reported that the peak in wart diagnosis occurred in the 25-34-year-old age group in women and in the 35-44-year-old age group in men [13] . It has been hypothesized that the observed age lag in men is due to sexual mixing patterns in the population, with infections predominantly transmitted between older men and younger women. Although this phenomenon is likely true, the difference may also be due in part to a relatively longer time from incident HPV-6 or HPV-11 infection to wart development in men versus women, as observed in our study populations.
In conclusion, we found that genital wart development was common after incident infection with HPV-6 or HPV-11 and rare after infection with other alpha genus HPV types among healthy male university students. Although these results were similar to those found in a cohort of healthy young university women, the median time to wart detection among young men was ∼3 times longer than that observed among young women. Whether delayed wart development in men affects transmission probabilities and therapeutic outcomes requires further investigation.
